```html

Xerophthalmic Keratopathy – A Complete Guide

What is Xerophthalmic keratopathy?

Xerophthalmic keratopathy (also spelled xerophthalmic keratitis) is a degenerative disorder of the cornea that results from chronic dryness of the ocular surface. The term “xerophthalmic” comes from the Greek words xeros (dry) and ophthalmos (eye). When the tear film cannot adequately lubricate the cornea, the epithelium becomes thin, opaque, and vulnerable to injury, eventually leading to visual impairment if left untreated.

The condition is most often seen in people with severe dry‑eye disease, but it can also occur secondary to systemic illnesses, ocular surface disorders, or medications that reduce tear production. It is considered a late‑stage manifestation of ocular surface failure, meaning that early intervention can often halt or even reverse the changes before permanent scarring occurs.

Key point: Xerophthalmic keratopathy is not an infection; it is a structural change driven by chronic dryness and inflammation.

Common Causes

Several diseases, environmental factors, and iatrogenic (medication‑related) conditions can lead to xerophthalmic keratopathy. The most frequent contributors are listed below.

• Severe aqueous‑deficient dry eye (Sjögren’s syndrome): Autoimmune destruction of lacrimal glands reduces tear production.
• Medication‑induced dry eye: Antihistamines, antidepressants, isotretinoin, and some chemotherapy agents impair tear secretion.
• Meibomian gland dysfunction (MGD): Poor lipid layer formation leads to rapid tear evaporation.
• Radiation or chemotherapy for head‑and‑neck cancers: Damage to lacrimal tissue can produce chronic dryness.
• Viral conjunctivitis (e.g., adenovirus, herpes simplex): Repeated inflammation damages goblet cells and reduces mucin production.
• Exposure keratopathy: Incomplete eyelid closure (lagophthalmos) from Bell’s palsy, facial trauma, or postoperative swelling.
• Systemic autoimmune diseases: Rheumatoid arthritis, graft‑versus‑host disease, and systemic lupus erythematosus can all affect tear film quality.
• Environmental extremes: Low humidity, wind, air‑conditioned or heated rooms, and prolonged screen time exacerbate tear evaporation.
• Vitamin A deficiency: Historically a major cause in developing countries; vitamin A is essential for goblet cell function.
• Neurotrophic keratopathy: Damage to corneal sensory nerves (e.g., after trigeminal nerve injury) reduces blink reflexes and tear reflexes.

Associated Symptoms

Patients with xerophthalmic keratopathy often report a constellation of ocular complaints that reflect the underlying dryness and surface compromise.

• Persistent gritty or foreign‑body sensation
• Burning or stinging pain, especially after prolonged visual tasks
• Redness of the eye (conjunctival injection)
• Excessive tearing (reflex tearing) that paradoxically co‑exists with dryness
• Photophobia (light sensitivity)
• Fluctuating vision that improves with blinking
• White or grayish spots on the cornea that may spread centrally
• Difficulty wearing contact lenses
• Feeling of a “film” over the eye that does not clear with blinking

When to See a Doctor

Because xerophthalmic keratopathy can progress to irreversible corneal scarring, timely evaluation is critical. Seek professional care if you notice any of the following:

• Vision that does not improve after blinking or lubricating drops
• New onset of dense white spots or “opacity” on the cornea
• Severe pain that is not relieved by over‑the‑counter artificial tears
• Persistent redness lasting more than a few days
• Signs of infection: pus, sudden swelling, or a worsening discharge
• History of autoimmune disease, recent radiation, or surgery involving the eye or eyelids

Early ophthalmologic assessment can prevent permanent vision loss.

Diagnosis

Ophthalmologists use a combination of patient history, slit‑lamp examination, and specialized tests to confirm xerophthalmic keratopathy.

Clinical evaluation

• History taking: Duration of dry‑eye symptoms, medication list, systemic illnesses, occupational exposures, and prior eye surgeries.
• Visual acuity testing: Baseline measurement to monitor progression.
• Slit‑lamp biomicroscopy: Direct visualization of corneal opacity, epithelial defects, and loss of surface regularity.
• Fluorescein staining: Highlights areas of epithelial breakdown; the pattern (e.g., punctate vs. geographic) helps stage severity.

Objective tear‑film testing

• Schirmer I test: Measures basal tear production with filter paper strips placed in the lower lid.
• Tear break‑up time (TBUT): assesses tear film stability; a time <10 seconds is abnormal.
• Ocular surface disease index (OSDI) questionnaire: Standardized symptom scoring.

Additional investigations (when indicated)

• Meibography – imaging of meibomian glands to evaluate lipid deficiency.
• Confocal microscopy – to assess corneal nerve density in neurotrophic cases.
• Blood work – auto‑antibody panels (e.g., anti‑SSA/SSB for Sjögren’s), vitamin A levels, and inflammatory markers.

Treatment Options

Treatment is multimodal, aiming to restore a stable tear film, protect the corneal epithelium, and address the underlying cause.

Medical (prescription) therapies

• Anti‑inflammatory drops: Topical cyclosporine 0.05% (Restasis) or lifitegrast 5% (Xiidra) improve tear production by reducing ocular surface inflammation.
• Corticosteroid eye drops: Short‑course prednisolone acetate 1% for acute flare‑ups; must be tapered to avoid glaucoma or cataract formation.
• Autologous serum eye drops: Contain growth factors and vitamins; useful for severe epithelial defects.
• Punctal plugs: Silicone or collagen plugs placed in the lacrimal puncta to conserve tears.
• Systemic medications: Oral doxycycline 40 mg daily for its anti‑matrix‑metalloproteinase effect; essential fatty acid supplements (omega‑3) to improve meibomian gland secretions.
• Vitamin A supplementation: For documented deficiency, oral retinol 10,000 IU daily under medical supervision.

Procedural interventions

• Thermal pulsation (e.g., LipiFlow): Improves meibomian gland function.
• Amniotic membrane transplantation: Provides a biologic bandage for non‑healing epithelial defects.
• Corneal laser ablation or phototherapeutic keratectomy (PTK): Used in advanced cases to remove superficial scar tissue.

Home and lifestyle measures

• Apply preservative‑free artificial tears 4–6 times daily; increase frequency in dry environments.
• Use eyelid hygiene: warm compresses for 5‑10 minutes followed by gentle lid scrubs (e.g., diluted baby shampoo).
• Wear protective goggles outdoors to shield eyes from wind and dust.
• Humidify indoor air (30‑40% relative humidity) especially in arid climates.
• Take regular breaks during screen use (20‑20‑20 rule: every 20 min, look at something 20 ft away for 20 seconds).
• Avoid smoking and limit alcohol, both of which exacerbate tear evaporation.

Prevention Tips

While some risk factors (e.g., autoimmune disease) cannot be eliminated, many strategies reduce the likelihood of progressing to xerophthalmic keratopathy.

• Schedule routine eye exams, especially if you have known dry‑eye risk factors.
• Maintain optimal hydration and a diet rich in omega‑3 fatty acids (fish, flaxseed, walnuts).
• Use preservative‑free lubricants before prolonged visual tasks or in air‑conditioned rooms.
• Promptly treat underlying conditions such as blepharitis, MGD, or thyroid eye disease.
• Review all systemic medications with your physician; ask about alternatives if they cause dry eye.
• Protect the eyes during surgeries or procedures that involve general anesthesia, which can reduce blink reflex.
• For contact lens wearers, consider daily‑disposable lenses and ensure proper lens hygiene to avoid surface irritation.

Emergency Warning Signs

Key Take‑aways

Xerophthalmic keratopathy is a preventable and treatable consequence of chronic ocular surface dryness. Early recognition, aggressive lubrication, control of inflammation, and treatment of the underlying cause can halt progression and often restore normal vision. Patients should remain vigilant for worsening symptoms and seek prompt professional care when red‑flag signs appear.

```